UK - The Capital Fund backs Biocontrol with £500,000

The Capital Fund has invested ТЃ250,000 as part of a ТЃ500,000 funding round in Biocontrol. Biocontrol's research focuses on developing the clinical use of bacteriophages, that is naturally occuring viruses, which attack and destroy harmful bacteria.